Harnessing biomaterials for therapeutic strategies against COVID-19.
Journal
Emergent materials
ISSN: 2522-574X
Titre abrégé: Emergent Mater
Pays: Switzerland
ID NLM: 101752456
Informations de publication
Date de publication:
2021
2021
Historique:
received:
08
12
2020
accepted:
24
01
2021
pubmed:
13
4
2021
medline:
13
4
2021
entrez:
12
4
2021
Statut:
ppublish
Résumé
With the emergence of the coronavirus disease 2019 (COVID-19), the world is experiencing a profound human health crisis. The number of infections and deaths due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to increase every minute, pinpointing major shortcomings in our ability to prevent viral outbreaks. Although several COVID-19 vaccines have been recently approved for emergency use, therapeutic options remain limited, and their long-term potency has yet to be validated. Biomaterials science has a pivotal role to play in pushing the boundaries of emerging technologies for antiviral research and treatment. In this perspective, we discuss how biomaterials can be harnessed to develop accurate COVID-19 infection models, enhance antiviral drug delivery, foster new antiviral strategies, and boost vaccine efficacy. These efforts will not only contribute to stop or mitigate the current pandemic but will also provide unorthodox platforms to understand, prevent, and protect us from future viral outbreaks.
Identifiants
pubmed: 33842840
doi: 10.1007/s42247-021-00171-z
pii: 171
pmc: PMC8022295
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
9-18Informations de copyright
© Qatar University and Springer Nature Switzerland AG 2021.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare no competing interests.
Références
Biomater Sci. 2021 Feb 21;9(4):1217-1226
pubmed: 33355542
Lancet Respir Med. 2020 Jul;8(7):e55-e56
pubmed: 32446313
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Open Biol. 2020 Aug;10(8):200208
pubmed: 32847471
N Engl J Med. 2014 Aug 14;371(7):635-45
pubmed: 25119609
Oncoimmunology. 2015 Jun 1;4(12):e1052934
pubmed: 26587328
Adv Sci (Weinh). 2021 Jul 20;8(18):2100316
pubmed: 34580619
Trends Biotechnol. 2020 Apr;38(4):418-431
pubmed: 31699534
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
ACS Nano. 2019 Oct 22;13(10):11034-11048
pubmed: 31603314
Front Immunol. 2020 Jun 23;11:1480
pubmed: 32655580
EBioMedicine. 2020 May;55:102743
pubmed: 32249203
Adv Sci (Weinh). 2019 Jul 15;6(16):1900288
pubmed: 31453059
Cytokine Growth Factor Rev. 2020 Jun;53:13-24
pubmed: 32475759
Adv Mater. 2019 Dec;31(50):e1902042
pubmed: 31282047
Adv Mater. 2009 Feb 23;21(8):847-867
pubmed: 28413262
Tissue Eng Part A. 2018 Oct;24(19-20):1468-1480
pubmed: 29732955
Sci Rep. 2020 Oct 27;10(1):18370
pubmed: 33110210
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27141-27147
pubmed: 33024017
Nanomaterials (Basel). 2017 Dec 10;7(12):
pubmed: 29232876
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Nat Rev Mater. 2019 Sep;4(9):606-622
pubmed: 33552558
Nat Rev Immunol. 2019 Jan;19(1):19-30
pubmed: 30429578
Int J Bioprint. 2020 Aug 28;6(4):302
pubmed: 33089000
Regen Biomater. 2016 Jun;3(2):99-105
pubmed: 27047675
Nat Rev Immunol. 2002 Sep;2(9):706-13
pubmed: 12209139
Mol Ther. 2018 Feb 7;26(2):446-455
pubmed: 29275847
Sci Rep. 2019 Apr 25;9(1):6535
pubmed: 31024011
Nat Rev Drug Discov. 2008 Sep;7(9):771-82
pubmed: 18758474
Clin Transl Sci. 2021 Jan;14(1):132-136
pubmed: 33135382
Nat Rev Mater. 2016 Dec;1(12):
pubmed: 29657852
FEBS Lett. 1996 Feb 12;380(1-2):108-12
pubmed: 8603716
N Engl J Med. 2020 Aug 6;383(6):517-525
pubmed: 32492293
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16473-16478
pubmed: 31358641
Nat Immunol. 2018 Jan;19(1):20-28
pubmed: 29199281
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
Int J Biomater. 2016;2016:8043983
pubmed: 27242902
J Infect. 2020 Sep;81(3):e41-e43
pubmed: 32603675
Cell Discov. 2020 Mar 18;6:16
pubmed: 32194981
J Med Toxicol. 2020 Jul;16(3):284-294
pubmed: 32356252
Paediatr Respir Rev. 2020 Sep;35:43-49
pubmed: 32653463
Nat Rev Cancer. 2016 Jan;16(1):56-66
pubmed: 26694936
Nat Nanotechnol. 2020 Aug;15(8):622-624
pubmed: 32747742
J Med Chem. 2016 Apr 14;59(7):3046-62
pubmed: 26943260
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
J Biomed Mater Res A. 2020 Oct;108(10):1974-1990
pubmed: 32662571
Materials (Basel). 2018 Aug 07;11(8):
pubmed: 30087295
Nat Med. 2020 Jul;26(7):1077-1083
pubmed: 32405028
Int J Biol Macromol. 2016 Dec;93(Pt B):1410-1419
pubmed: 27185069
Lancet Respir Med. 2020 Nov;8(11):1154-1158
pubmed: 33131609
Bioelectricity. 2020 Sep 1;2(3):279-292
pubmed: 34476358
Nat Rev Mater. 2020;5(11):847-860
pubmed: 33078077
Gels. 2019 Dec 03;5(4):
pubmed: 31816989
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Signal Transduct Target Ther. 2020 Nov 3;5(1):258
pubmed: 33144565
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Biomaterials. 2016 Apr;85:111-27
pubmed: 26871888
Nat Nanotechnol. 2020 Aug;15(8):646-655
pubmed: 32669664
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
N Engl J Med. 2020 Dec 10;383(24):2320-2332
pubmed: 32877576
Sci Bull (Beijing). 2021 Apr 30;66(8):783-793
pubmed: 33282445
Vaccine. 2012 Jan 5;30(2):414-24
pubmed: 22075093
Front Chem. 2020 Oct 30;8:598160
pubmed: 33195107
AIDS. 2014 Nov 13;28(17):2625-7
pubmed: 25102089
N Engl J Med. 2020 Nov 12;383(20):1986-1988
pubmed: 32663910
Nature. 2020 Oct;586(7830):516-527
pubmed: 32967006
DNA Res. 2014 Dec;21(6):673-83
pubmed: 25267831
Sci Transl Med. 2015 Jun 3;7(290):290ra89
pubmed: 26041706
Biomater Sci. 2020 Aug 7;8(15):4073-4094
pubmed: 32539055
Nat Commun. 2020 Jul 9;11(1):3523
pubmed: 32647131
JAMA Intern Med. 2021 Feb 1;181(2):195-202
pubmed: 33001138
Trends Pharmacol Sci. 2020 Aug;41(8):513-517
pubmed: 32553545
Antiviral Res. 2017 Feb;138:47-56
pubmed: 27919709
Nature. 2021 Jan;589(7841):270-275
pubmed: 33116299
Biomater Sci. 2020 Dec 15;8(24):7106-7116
pubmed: 33089849
Tissue Eng Part A. 2021 Jun;27(11-12):748-760
pubmed: 33108972
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11488-11493
pubmed: 29073076
Nat Rev Mater. 2020 Jul;5(7):539-551
pubmed: 32953138
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Front Microbiol. 2020 Jul 14;11:1723
pubmed: 32765482
Clin Infect Dis. 2020 Dec 15;71(12):3232-3236
pubmed: 32435791
Front Bioeng Biotechnol. 2020 Jun 05;8:559
pubmed: 32582676
Nano Lett. 2020 Jul 8;20(7):5570-5574
pubmed: 32551679
Adv Healthc Mater. 2019 Sep;8(17):e1900679
pubmed: 31348620
Cell. 2020 Sep 3;182(5):1271-1283.e16
pubmed: 32795413